» Articles » PMID: 20056541

Piperidine-derived Gamma-secretase Modulators

Overview
Specialty Biochemistry
Date 2010 Jan 9
PMID 20056541
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

This Letter details the SAR of a novel series of piperidine-derived gamma-secretase modulators. Compound 10h was found to be a potent modulator in vitro, which on further profiling, was found to decrease Abeta42, increase Abeta38 and have no effect on Abeta40 levels. Furthermore, 10h demonstrated excellent pharmacokinetic parameters in the mouse, rat and dog in addition to good CNS penetration in the mouse.

Citing Articles

Targeting Amyloidogenic Processing of APP in Alzheimer's Disease.

Zhao J, Liu X, Xia W, Zhang Y, Wang C Front Mol Neurosci. 2020; 13:137.

PMID: 32848600 PMC: 7418514. DOI: 10.3389/fnmol.2020.00137.


γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase.

Nie P, Vartak A, Li Y Semin Cell Dev Biol. 2020; 105:43-53.

PMID: 32249070 PMC: 7483676. DOI: 10.1016/j.semcdb.2020.03.002.


γ-Secretase and its modulators: Twenty years and beyond.

Xia W Neurosci Lett. 2019; 701:162-169.

PMID: 30763650 PMC: 7008970. DOI: 10.1016/j.neulet.2019.02.011.


Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.

Kulshreshtha A, Piplani P Neurol Sci. 2016; 37(9):1403-35.

PMID: 27250365 DOI: 10.1007/s10072-016-2625-7.


Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials.

Jia Q, Deng Y, Qing H Biomed Res Int. 2014; 2014:837157.

PMID: 25136630 PMC: 4124758. DOI: 10.1155/2014/837157.